Iron Chelating Agents

Iron chelating agents are a therapeutic class of medications designed to bind free and stored trivalent ferric iron to form stable, non-toxic complexes that are subsequently eliminated from the body via urinary or fecal excretion

Iron chelating agents are a therapeutic class of medications designed to bind free and stored trivalent ferric iron to form stable, non-toxic complexes that are subsequently eliminated from the body via urinary or fecal excretion By removing excess metal, these agents mitigate oxidative tissue damage and prevent iron-induced toxicity in critical organs such as the heart, liver, and endocrine glands

By removing excess metal, these agents mitigate oxidative tissue damage and prevent iron-induced toxicity in critical organs such as the heart, liver, and endocrine glands They are primarily indicated to manage chronic transfusional iron overload in patients requiring repetitive blood transfusions for chronic anemias—including beta-thalassemia, sickle cell disease, and myelodysplastic syndromes—as well as non-transfusion-dependent thalassemia and acute iron poisoning

They are primarily indicated to manage chronic transfusional iron overload in patients requiring repetitive blood transfusions for chronic anemias—including beta-thalassemia, sickle cell disease, and myelodysplastic syndromes—as well as non-transfusion-dependent thalassemia and acute iron poisoning

They are primarily indicated to manage chronic transfusional iron overload in patients requiring repetitive blood transfusions for chronic anemias—including beta-thalassemia, sickle cell disease, and myelodysplastic syndromes—as well as non-transfusion-dependent thalassemia and acute iron poisoning